nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—seminal vesicle—testicular cancer	0.0836	0.402	CbGeAlD
Icosapent ethyl—DGAT1—female gonad—testicular cancer	0.0491	0.236	CbGeAlD
Icosapent ethyl—DGAT1—testis—testicular cancer	0.0435	0.21	CbGeAlD
Icosapent ethyl—DGAT1—lymph node—testicular cancer	0.0315	0.152	CbGeAlD
Icosapent ethyl—Anorexia—Ifosfamide—testicular cancer	0.00176	0.00222	CcSEcCtD
Icosapent ethyl—Malaise—Cisplatin—testicular cancer	0.00176	0.00222	CcSEcCtD
Icosapent ethyl—Decreased appetite—Dactinomycin—testicular cancer	0.00175	0.00221	CcSEcCtD
Icosapent ethyl—Dysgeusia—Etoposide—testicular cancer	0.00175	0.00221	CcSEcCtD
Icosapent ethyl—Back pain—Etoposide—testicular cancer	0.00173	0.00218	CcSEcCtD
Icosapent ethyl—Pain—Dactinomycin—testicular cancer	0.00172	0.00217	CcSEcCtD
Icosapent ethyl—Eczema—Doxorubicin—testicular cancer	0.00171	0.00216	CcSEcCtD
Icosapent ethyl—Body temperature increased—Bleomycin—testicular cancer	0.00171	0.00215	CcSEcCtD
Icosapent ethyl—Dizziness—Vinblastine—testicular cancer	0.00169	0.00213	CcSEcCtD
Icosapent ethyl—Mood swings—Methotrexate—testicular cancer	0.00168	0.00212	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00168	0.00212	CcSEcCtD
Icosapent ethyl—Myalgia—Cisplatin—testicular cancer	0.00166	0.00209	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Dactinomycin—testicular cancer	0.00166	0.00209	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Etoposide—testicular cancer	0.00166	0.00209	CcSEcCtD
Icosapent ethyl—Dyspnoea—Ifosfamide—testicular cancer	0.00164	0.00208	CcSEcCtD
Icosapent ethyl—Discomfort—Cisplatin—testicular cancer	0.00164	0.00207	CcSEcCtD
Icosapent ethyl—Increased appetite—Doxorubicin—testicular cancer	0.00164	0.00206	CcSEcCtD
Icosapent ethyl—Affect lability—Epirubicin—testicular cancer	0.00164	0.00206	CcSEcCtD
Icosapent ethyl—Migraine—Epirubicin—testicular cancer	0.00164	0.00206	CcSEcCtD
Icosapent ethyl—Vomiting—Vinblastine—testicular cancer	0.00162	0.00205	CcSEcCtD
Icosapent ethyl—Malaise—Etoposide—testicular cancer	0.00161	0.00203	CcSEcCtD
Icosapent ethyl—Vertigo—Etoposide—testicular cancer	0.0016	0.00202	CcSEcCtD
Icosapent ethyl—Decreased appetite—Ifosfamide—testicular cancer	0.0016	0.00202	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00159	0.00201	CcSEcCtD
Icosapent ethyl—Body temperature increased—Dactinomycin—testicular cancer	0.00159	0.00201	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Cisplatin—testicular cancer	0.00159	0.00201	CcSEcCtD
Icosapent ethyl—Oedema—Cisplatin—testicular cancer	0.00159	0.00201	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Epirubicin—testicular cancer	0.00158	0.00199	CcSEcCtD
Icosapent ethyl—Infection—Cisplatin—testicular cancer	0.00158	0.00199	CcSEcCtD
Icosapent ethyl—Constipation—Ifosfamide—testicular cancer	0.00158	0.00199	CcSEcCtD
Icosapent ethyl—Pain—Ifosfamide—testicular cancer	0.00158	0.00199	CcSEcCtD
Icosapent ethyl—Mood swings—Epirubicin—testicular cancer	0.00157	0.00199	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Etoposide—testicular cancer	0.00157	0.00198	CcSEcCtD
Icosapent ethyl—Cough—Etoposide—testicular cancer	0.00156	0.00197	CcSEcCtD
Icosapent ethyl—Tachycardia—Cisplatin—testicular cancer	0.00155	0.00196	CcSEcCtD
Icosapent ethyl—Asthenia—Bleomycin—testicular cancer	0.00155	0.00195	CcSEcCtD
Icosapent ethyl—Hypertension—Etoposide—testicular cancer	0.00154	0.00194	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Cisplatin—testicular cancer	0.00154	0.00194	CcSEcCtD
Icosapent ethyl—Asthma—Methotrexate—testicular cancer	0.00153	0.00194	CcSEcCtD
Icosapent ethyl—Pruritus—Bleomycin—testicular cancer	0.00153	0.00193	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Ifosfamide—testicular cancer	0.00152	0.00192	CcSEcCtD
Icosapent ethyl—Chest pain—Etoposide—testicular cancer	0.00152	0.00192	CcSEcCtD
Icosapent ethyl—Anorexia—Cisplatin—testicular cancer	0.00152	0.00191	CcSEcCtD
Icosapent ethyl—Affect lability—Doxorubicin—testicular cancer	0.00151	0.00191	CcSEcCtD
Icosapent ethyl—Migraine—Doxorubicin—testicular cancer	0.00151	0.00191	CcSEcCtD
Icosapent ethyl—Pancreatitis—Methotrexate—testicular cancer	0.0015	0.0019	CcSEcCtD
Icosapent ethyl—Discomfort—Etoposide—testicular cancer	0.0015	0.00189	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Epirubicin—testicular cancer	0.0015	0.00189	CcSEcCtD
Icosapent ethyl—Gastritis—Epirubicin—testicular cancer	0.00147	0.00186	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.00147	0.00185	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Doxorubicin—testicular cancer	0.00146	0.00184	CcSEcCtD
Icosapent ethyl—Body temperature increased—Ifosfamide—testicular cancer	0.00146	0.00184	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Etoposide—testicular cancer	0.00146	0.00184	CcSEcCtD
Icosapent ethyl—Mood swings—Doxorubicin—testicular cancer	0.00146	0.00184	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00145	0.00183	CcSEcCtD
Icosapent ethyl—Infection—Etoposide—testicular cancer	0.00145	0.00183	CcSEcCtD
Icosapent ethyl—Abdominal distension—Epirubicin—testicular cancer	0.00145	0.00182	CcSEcCtD
Icosapent ethyl—Asthenia—Dactinomycin—testicular cancer	0.00144	0.00182	CcSEcCtD
Icosapent ethyl—Dysphagia—Epirubicin—testicular cancer	0.00144	0.00181	CcSEcCtD
Icosapent ethyl—Influenza—Epirubicin—testicular cancer	0.00144	0.00181	CcSEcCtD
Icosapent ethyl—Asthma—Epirubicin—testicular cancer	0.00144	0.00181	CcSEcCtD
Icosapent ethyl—Tachycardia—Etoposide—testicular cancer	0.00142	0.00179	CcSEcCtD
Icosapent ethyl—Dyspnoea—Cisplatin—testicular cancer	0.00142	0.00179	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Methotrexate—testicular cancer	0.00141	0.00178	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Etoposide—testicular cancer	0.00141	0.00178	CcSEcCtD
Icosapent ethyl—Pancreatitis—Epirubicin—testicular cancer	0.00141	0.00178	CcSEcCtD
Icosapent ethyl—Angina pectoris—Epirubicin—testicular cancer	0.0014	0.00177	CcSEcCtD
Icosapent ethyl—Anorexia—Etoposide—testicular cancer	0.00139	0.00175	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.00138	0.00175	CcSEcCtD
Icosapent ethyl—Decreased appetite—Cisplatin—testicular cancer	0.00138	0.00174	CcSEcCtD
Icosapent ethyl—Bronchitis—Epirubicin—testicular cancer	0.00138	0.00174	CcSEcCtD
Icosapent ethyl—Pneumonia—Methotrexate—testicular cancer	0.00138	0.00174	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00137	0.00173	CcSEcCtD
Icosapent ethyl—Vomiting—Bleomycin—testicular cancer	0.00137	0.00173	CcSEcCtD
Icosapent ethyl—Infestation—Methotrexate—testicular cancer	0.00137	0.00173	CcSEcCtD
Icosapent ethyl—Infestation NOS—Methotrexate—testicular cancer	0.00137	0.00173	CcSEcCtD
Icosapent ethyl—Rash—Bleomycin—testicular cancer	0.00136	0.00172	CcSEcCtD
Icosapent ethyl—Gastritis—Doxorubicin—testicular cancer	0.00136	0.00172	CcSEcCtD
Icosapent ethyl—Pain—Cisplatin—testicular cancer	0.00136	0.00172	CcSEcCtD
Icosapent ethyl—Dermatitis—Bleomycin—testicular cancer	0.00136	0.00172	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.00136	0.00171	CcSEcCtD
Icosapent ethyl—Abdominal distension—Doxorubicin—testicular cancer	0.00134	0.00169	CcSEcCtD
Icosapent ethyl—Dysphagia—Doxorubicin—testicular cancer	0.00133	0.00168	CcSEcCtD
Icosapent ethyl—Asthma—Doxorubicin—testicular cancer	0.00133	0.00168	CcSEcCtD
Icosapent ethyl—Influenza—Doxorubicin—testicular cancer	0.00133	0.00168	CcSEcCtD
Icosapent ethyl—Asthenia—Ifosfamide—testicular cancer	0.00132	0.00167	CcSEcCtD
Icosapent ethyl—Sweating—Methotrexate—testicular cancer	0.00131	0.00166	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Cisplatin—testicular cancer	0.00131	0.00165	CcSEcCtD
Icosapent ethyl—Pruritus—Ifosfamide—testicular cancer	0.0013	0.00165	CcSEcCtD
Icosapent ethyl—Pancreatitis—Doxorubicin—testicular cancer	0.0013	0.00164	CcSEcCtD
Icosapent ethyl—Dyspnoea—Etoposide—testicular cancer	0.0013	0.00164	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Epirubicin—testicular cancer	0.0013	0.00163	CcSEcCtD
Icosapent ethyl—Angina pectoris—Doxorubicin—testicular cancer	0.00129	0.00163	CcSEcCtD
Icosapent ethyl—Epistaxis—Methotrexate—testicular cancer	0.00129	0.00163	CcSEcCtD
Icosapent ethyl—Pneumonia—Epirubicin—testicular cancer	0.00129	0.00163	CcSEcCtD
Icosapent ethyl—Infestation NOS—Epirubicin—testicular cancer	0.00128	0.00162	CcSEcCtD
Icosapent ethyl—Infestation—Epirubicin—testicular cancer	0.00128	0.00162	CcSEcCtD
Icosapent ethyl—Vomiting—Dactinomycin—testicular cancer	0.00128	0.00162	CcSEcCtD
Icosapent ethyl—Bronchitis—Doxorubicin—testicular cancer	0.00128	0.00161	CcSEcCtD
Icosapent ethyl—Rash—Dactinomycin—testicular cancer	0.00127	0.0016	CcSEcCtD
Icosapent ethyl—Decreased appetite—Etoposide—testicular cancer	0.00127	0.0016	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Etoposide—testicular cancer	0.00126	0.00159	CcSEcCtD
Icosapent ethyl—Body temperature increased—Cisplatin—testicular cancer	0.00126	0.00159	CcSEcCtD
Icosapent ethyl—Constipation—Etoposide—testicular cancer	0.00125	0.00157	CcSEcCtD
Icosapent ethyl—Pain—Etoposide—testicular cancer	0.00125	0.00157	CcSEcCtD
Icosapent ethyl—Sweating—Epirubicin—testicular cancer	0.00123	0.00155	CcSEcCtD
Icosapent ethyl—Dizziness—Ifosfamide—testicular cancer	0.00122	0.00154	CcSEcCtD
Icosapent ethyl—Pharyngitis—Methotrexate—testicular cancer	0.00122	0.00154	CcSEcCtD
Icosapent ethyl—Epistaxis—Epirubicin—testicular cancer	0.00121	0.00152	CcSEcCtD
Icosapent ethyl—Sinusitis—Epirubicin—testicular cancer	0.0012	0.00152	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Etoposide—testicular cancer	0.0012	0.00151	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Doxorubicin—testicular cancer	0.0012	0.00151	CcSEcCtD
Icosapent ethyl—Pneumonia—Doxorubicin—testicular cancer	0.00119	0.0015	CcSEcCtD
Icosapent ethyl—Infestation—Doxorubicin—testicular cancer	0.00118	0.0015	CcSEcCtD
Icosapent ethyl—Infestation NOS—Doxorubicin—testicular cancer	0.00118	0.0015	CcSEcCtD
Icosapent ethyl—Vomiting—Ifosfamide—testicular cancer	0.00117	0.00148	CcSEcCtD
Icosapent ethyl—Rash—Ifosfamide—testicular cancer	0.00116	0.00147	CcSEcCtD
Icosapent ethyl—Dermatitis—Ifosfamide—testicular cancer	0.00116	0.00147	CcSEcCtD
Icosapent ethyl—Rhinitis—Epirubicin—testicular cancer	0.00115	0.00145	CcSEcCtD
Icosapent ethyl—Body temperature increased—Etoposide—testicular cancer	0.00115	0.00145	CcSEcCtD
Icosapent ethyl—Asthenia—Cisplatin—testicular cancer	0.00114	0.00144	CcSEcCtD
Icosapent ethyl—Pharyngitis—Epirubicin—testicular cancer	0.00114	0.00144	CcSEcCtD
Icosapent ethyl—Sweating—Doxorubicin—testicular cancer	0.00114	0.00143	CcSEcCtD
Icosapent ethyl—Epistaxis—Doxorubicin—testicular cancer	0.00112	0.00141	CcSEcCtD
Icosapent ethyl—Sinusitis—Doxorubicin—testicular cancer	0.00111	0.0014	CcSEcCtD
Icosapent ethyl—Chills—Methotrexate—testicular cancer	0.0011	0.00139	CcSEcCtD
Icosapent ethyl—Alopecia—Methotrexate—testicular cancer	0.00109	0.00137	CcSEcCtD
Icosapent ethyl—Malnutrition—Methotrexate—testicular cancer	0.00107	0.00135	CcSEcCtD
Icosapent ethyl—Rhinitis—Doxorubicin—testicular cancer	0.00107	0.00135	CcSEcCtD
Icosapent ethyl—Pharyngitis—Doxorubicin—testicular cancer	0.00106	0.00133	CcSEcCtD
Icosapent ethyl—Dysgeusia—Methotrexate—testicular cancer	0.00105	0.00132	CcSEcCtD
Icosapent ethyl—Asthenia—Etoposide—testicular cancer	0.00105	0.00132	CcSEcCtD
Icosapent ethyl—Back pain—Methotrexate—testicular cancer	0.00103	0.00131	CcSEcCtD
Icosapent ethyl—Chills—Epirubicin—testicular cancer	0.00103	0.0013	CcSEcCtD
Icosapent ethyl—Pruritus—Etoposide—testicular cancer	0.00103	0.0013	CcSEcCtD
Icosapent ethyl—Arrhythmia—Epirubicin—testicular cancer	0.00103	0.0013	CcSEcCtD
Icosapent ethyl—Alopecia—Epirubicin—testicular cancer	0.00102	0.00128	CcSEcCtD
Icosapent ethyl—Vomiting—Cisplatin—testicular cancer	0.00101	0.00128	CcSEcCtD
Icosapent ethyl—Rash—Cisplatin—testicular cancer	0.001	0.00127	CcSEcCtD
Icosapent ethyl—Dermatitis—Cisplatin—testicular cancer	0.001	0.00126	CcSEcCtD
Icosapent ethyl—Malnutrition—Epirubicin—testicular cancer	0.001	0.00126	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Methotrexate—testicular cancer	0.000992	0.00125	CcSEcCtD
Icosapent ethyl—Dysgeusia—Epirubicin—testicular cancer	0.00098	0.00124	CcSEcCtD
Icosapent ethyl—Back pain—Epirubicin—testicular cancer	0.000968	0.00122	CcSEcCtD
Icosapent ethyl—Malaise—Methotrexate—testicular cancer	0.000964	0.00122	CcSEcCtD
Icosapent ethyl—Dizziness—Etoposide—testicular cancer	0.000963	0.00122	CcSEcCtD
Icosapent ethyl—Vertigo—Methotrexate—testicular cancer	0.00096	0.00121	CcSEcCtD
Icosapent ethyl—Chills—Doxorubicin—testicular cancer	0.000954	0.0012	CcSEcCtD
Icosapent ethyl—Arrhythmia—Doxorubicin—testicular cancer	0.00095	0.0012	CcSEcCtD
Icosapent ethyl—Alopecia—Doxorubicin—testicular cancer	0.00094	0.00119	CcSEcCtD
Icosapent ethyl—Cough—Methotrexate—testicular cancer	0.000933	0.00118	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Epirubicin—testicular cancer	0.000928	0.00117	CcSEcCtD
Icosapent ethyl—Vomiting—Etoposide—testicular cancer	0.000926	0.00117	CcSEcCtD
Icosapent ethyl—Malnutrition—Doxorubicin—testicular cancer	0.000926	0.00117	CcSEcCtD
Icosapent ethyl—Rash—Etoposide—testicular cancer	0.000918	0.00116	CcSEcCtD
Icosapent ethyl—Dermatitis—Etoposide—testicular cancer	0.000918	0.00116	CcSEcCtD
Icosapent ethyl—Myalgia—Methotrexate—testicular cancer	0.00091	0.00115	CcSEcCtD
Icosapent ethyl—Arthralgia—Methotrexate—testicular cancer	0.00091	0.00115	CcSEcCtD
Icosapent ethyl—Chest pain—Methotrexate—testicular cancer	0.00091	0.00115	CcSEcCtD
Icosapent ethyl—Dysgeusia—Doxorubicin—testicular cancer	0.000906	0.00114	CcSEcCtD
Icosapent ethyl—Malaise—Epirubicin—testicular cancer	0.000902	0.00114	CcSEcCtD
Icosapent ethyl—Discomfort—Methotrexate—testicular cancer	0.000899	0.00113	CcSEcCtD
Icosapent ethyl—Vertigo—Epirubicin—testicular cancer	0.000899	0.00113	CcSEcCtD
Icosapent ethyl—Syncope—Epirubicin—testicular cancer	0.000897	0.00113	CcSEcCtD
Icosapent ethyl—Back pain—Doxorubicin—testicular cancer	0.000895	0.00113	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Epirubicin—testicular cancer	0.000879	0.00111	CcSEcCtD
Icosapent ethyl—Cough—Epirubicin—testicular cancer	0.000873	0.0011	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Methotrexate—testicular cancer	0.000872	0.0011	CcSEcCtD
Icosapent ethyl—Infection—Methotrexate—testicular cancer	0.000867	0.00109	CcSEcCtD
Icosapent ethyl—Hypertension—Epirubicin—testicular cancer	0.000864	0.00109	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Doxorubicin—testicular cancer	0.000859	0.00108	CcSEcCtD
Icosapent ethyl—Myalgia—Epirubicin—testicular cancer	0.000852	0.00108	CcSEcCtD
Icosapent ethyl—Chest pain—Epirubicin—testicular cancer	0.000852	0.00108	CcSEcCtD
Icosapent ethyl—Arthralgia—Epirubicin—testicular cancer	0.000852	0.00108	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Methotrexate—testicular cancer	0.000843	0.00106	CcSEcCtD
Icosapent ethyl—Discomfort—Epirubicin—testicular cancer	0.000842	0.00106	CcSEcCtD
Icosapent ethyl—Malaise—Doxorubicin—testicular cancer	0.000835	0.00105	CcSEcCtD
Icosapent ethyl—Dry mouth—Epirubicin—testicular cancer	0.000833	0.00105	CcSEcCtD
Icosapent ethyl—Vertigo—Doxorubicin—testicular cancer	0.000832	0.00105	CcSEcCtD
Icosapent ethyl—Anorexia—Methotrexate—testicular cancer	0.000832	0.00105	CcSEcCtD
Icosapent ethyl—Syncope—Doxorubicin—testicular cancer	0.00083	0.00105	CcSEcCtD
Icosapent ethyl—Oedema—Epirubicin—testicular cancer	0.000816	0.00103	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Epirubicin—testicular cancer	0.000816	0.00103	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Doxorubicin—testicular cancer	0.000814	0.00103	CcSEcCtD
Icosapent ethyl—Infection—Epirubicin—testicular cancer	0.000811	0.00102	CcSEcCtD
Icosapent ethyl—Cough—Doxorubicin—testicular cancer	0.000808	0.00102	CcSEcCtD
Icosapent ethyl—Shock—Epirubicin—testicular cancer	0.000803	0.00101	CcSEcCtD
Icosapent ethyl—Hypertension—Doxorubicin—testicular cancer	0.000799	0.00101	CcSEcCtD
Icosapent ethyl—Tachycardia—Epirubicin—testicular cancer	0.000797	0.00101	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000795	0.001	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Epirubicin—testicular cancer	0.000789	0.000996	CcSEcCtD
Icosapent ethyl—Insomnia—Methotrexate—testicular cancer	0.000789	0.000996	CcSEcCtD
Icosapent ethyl—Myalgia—Doxorubicin—testicular cancer	0.000788	0.000995	CcSEcCtD
Icosapent ethyl—Chest pain—Doxorubicin—testicular cancer	0.000788	0.000995	CcSEcCtD
Icosapent ethyl—Arthralgia—Doxorubicin—testicular cancer	0.000788	0.000995	CcSEcCtD
Icosapent ethyl—Discomfort—Doxorubicin—testicular cancer	0.000779	0.000983	CcSEcCtD
Icosapent ethyl—Anorexia—Epirubicin—testicular cancer	0.000778	0.000982	CcSEcCtD
Icosapent ethyl—Dyspnoea—Methotrexate—testicular cancer	0.000778	0.000982	CcSEcCtD
Icosapent ethyl—Dry mouth—Doxorubicin—testicular cancer	0.000771	0.000973	CcSEcCtD
Icosapent ethyl—Dyspepsia—Methotrexate—testicular cancer	0.000768	0.000969	CcSEcCtD
Icosapent ethyl—Decreased appetite—Methotrexate—testicular cancer	0.000758	0.000957	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Doxorubicin—testicular cancer	0.000755	0.000954	CcSEcCtD
Icosapent ethyl—Oedema—Doxorubicin—testicular cancer	0.000755	0.000954	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000753	0.000951	CcSEcCtD
Icosapent ethyl—Infection—Doxorubicin—testicular cancer	0.000751	0.000947	CcSEcCtD
Icosapent ethyl—Pain—Methotrexate—testicular cancer	0.000746	0.000942	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000744	0.000939	CcSEcCtD
Icosapent ethyl—Shock—Doxorubicin—testicular cancer	0.000743	0.000938	CcSEcCtD
Icosapent ethyl—Insomnia—Epirubicin—testicular cancer	0.000738	0.000932	CcSEcCtD
Icosapent ethyl—Tachycardia—Doxorubicin—testicular cancer	0.000737	0.000931	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Doxorubicin—testicular cancer	0.00073	0.000922	CcSEcCtD
Icosapent ethyl—Dyspnoea—Epirubicin—testicular cancer	0.000728	0.000919	CcSEcCtD
Icosapent ethyl—Anorexia—Doxorubicin—testicular cancer	0.00072	0.000909	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Methotrexate—testicular cancer	0.000719	0.000907	CcSEcCtD
Icosapent ethyl—Dyspepsia—Epirubicin—testicular cancer	0.000719	0.000907	CcSEcCtD
Icosapent ethyl—Decreased appetite—Epirubicin—testicular cancer	0.00071	0.000896	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000705	0.00089	CcSEcCtD
Icosapent ethyl—Pain—Epirubicin—testicular cancer	0.000698	0.000881	CcSEcCtD
Icosapent ethyl—Constipation—Epirubicin—testicular cancer	0.000698	0.000881	CcSEcCtD
Icosapent ethyl—Body temperature increased—Methotrexate—testicular cancer	0.00069	0.000871	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000688	0.000869	CcSEcCtD
Icosapent ethyl—Insomnia—Doxorubicin—testicular cancer	0.000683	0.000862	CcSEcCtD
Icosapent ethyl—Dyspnoea—Doxorubicin—testicular cancer	0.000674	0.00085	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Epirubicin—testicular cancer	0.000673	0.000849	CcSEcCtD
Icosapent ethyl—Dyspepsia—Doxorubicin—testicular cancer	0.000665	0.000839	CcSEcCtD
Icosapent ethyl—Decreased appetite—Doxorubicin—testicular cancer	0.000657	0.000829	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000652	0.000823	CcSEcCtD
Icosapent ethyl—Pain—Doxorubicin—testicular cancer	0.000646	0.000815	CcSEcCtD
Icosapent ethyl—Constipation—Doxorubicin—testicular cancer	0.000646	0.000815	CcSEcCtD
Icosapent ethyl—Body temperature increased—Epirubicin—testicular cancer	0.000645	0.000815	CcSEcCtD
Icosapent ethyl—Asthenia—Methotrexate—testicular cancer	0.000626	0.00079	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Doxorubicin—testicular cancer	0.000623	0.000786	CcSEcCtD
Icosapent ethyl—Pruritus—Methotrexate—testicular cancer	0.000617	0.000779	CcSEcCtD
Icosapent ethyl—Body temperature increased—Doxorubicin—testicular cancer	0.000597	0.000754	CcSEcCtD
Icosapent ethyl—Asthenia—Epirubicin—testicular cancer	0.000586	0.000739	CcSEcCtD
Icosapent ethyl—Pruritus—Epirubicin—testicular cancer	0.000578	0.000729	CcSEcCtD
Icosapent ethyl—Dizziness—Methotrexate—testicular cancer	0.000577	0.000728	CcSEcCtD
Icosapent ethyl—Vomiting—Methotrexate—testicular cancer	0.000555	0.0007	CcSEcCtD
Icosapent ethyl—Rash—Methotrexate—testicular cancer	0.00055	0.000694	CcSEcCtD
Icosapent ethyl—Dermatitis—Methotrexate—testicular cancer	0.00055	0.000694	CcSEcCtD
Icosapent ethyl—Asthenia—Doxorubicin—testicular cancer	0.000542	0.000684	CcSEcCtD
Icosapent ethyl—Dizziness—Epirubicin—testicular cancer	0.00054	0.000681	CcSEcCtD
Icosapent ethyl—Pruritus—Doxorubicin—testicular cancer	0.000534	0.000675	CcSEcCtD
Icosapent ethyl—Vomiting—Epirubicin—testicular cancer	0.000519	0.000655	CcSEcCtD
Icosapent ethyl—Rash—Epirubicin—testicular cancer	0.000515	0.00065	CcSEcCtD
Icosapent ethyl—Dermatitis—Epirubicin—testicular cancer	0.000514	0.000649	CcSEcCtD
Icosapent ethyl—Dizziness—Doxorubicin—testicular cancer	0.0005	0.000631	CcSEcCtD
Icosapent ethyl—Vomiting—Doxorubicin—testicular cancer	0.00048	0.000606	CcSEcCtD
Icosapent ethyl—Rash—Doxorubicin—testicular cancer	0.000476	0.000601	CcSEcCtD
Icosapent ethyl—Dermatitis—Doxorubicin—testicular cancer	0.000476	0.000601	CcSEcCtD
